Gorka Etxebarria I Jardi

USPTO Granted Patents = 19 (Patent Applications = 6)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 8 (Patent Applications = 13)

Average Co-Inventor Count = 15.9

ph-index = 5

Forward Citations = 160(Granted Patents)

Company Filing History:

19 out of 1,152

Vertex Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12187731 - Compounds useful as inhibitors of ATR kinase (2025-01-07),

2. 12084438 - GCN2 inhibitors and uses thereof (2024-09-10),

3. 11485739 - Compounds useful as inhibitors of ATR kinase (2022-11-01),

4. 11370798 - Compounds useful as inhibitors of ATR kinase (2022-06-28),

5. 11117900 - Compounds useful as inhibitors of ATR kinase (2021-09-14),

6. 10988477 - GCN2 inhibitors and uses thereof (2021-04-27),

7. 10815239 - Compounds useful as inhibitors of ATR kinase (2020-10-27),

8. 10800781 - Compounds useful as inhibitors of ATR kinase (2020-10-13),

9. 10793563 - GCN2 inhibitors and uses thereof (2020-10-06),

10. 10787452 - Compounds useful as inhibitors of ATR kinase (2020-09-29),

11. 10392391 - Compounds useful as inhibitors of ATR kinase (2019-08-27),

12. 10160760 - Compounds useful as inhibitors of ATR kinase (2018-12-25),

13. 10093676 - Compounds useful as inhibitors of ATR kinase (2018-10-09),

14. 9718827 - Compounds useful as inhibitors of ATR kinase (2017-08-01),

15. 9670215 - Compounds useful as inhibitors of ATR kinase (2017-06-06),

Title: Gorka Etxebarria I Jardi: Pioneering Inventor in the Field of Pharmaceuticals

Introduction:

Gorka Etxebarria I Jardi, a renowned inventor based in Abingdon, GB, has made significant contributions to the field of pharmaceuticals. With an impressive portfolio of 18 patents, his innovative work has garnered attention worldwide.

Latest Patents:

Etxebarria's latest patents include groundbreaking inventions such as GCN2 inhibitors and their uses, as well as compounds designed as inhibitors of ATR protein kinase. These inventions have paved the way for new treatments and therapies in various diseases and conditions.

Career Highlights:

Throughout his career, Etxebarria has worked with leading companies in the pharmaceutical industry, including Vertex Pharmaceuticals, Inc. and Merck Patent GmbH. His expertise and dedication have led to the successful development and implementation of cutting-edge solutions.

Collaborations:

Etxebarria has collaborated with esteemed professionals in the field, including Jean-Damien Charrier and Damien Fraysse. Together, they have pushed the boundaries of pharmaceutical research and development, resulting in innovative products that have the potential to impact countless lives.

Conclusion:

In conclusion, Gorka Etxebarria I Jardi's remarkable achievements as an inventor in the pharmaceutical industry have solidified his reputation as a trailblazer. His relentless pursuit of innovation and commitment to excellence continue to drive progress in the field, shaping the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.